BioXcel Therapeutics BTAIQ
BioXcel Therapeutics, Inc. issued an updated corporate presentation
- Form
- 8-K
- Filed
- Period
- Importance
- Notable
- Accession
- 0001104659-24-049691
- Document
- 8-K
- Exhibit 99.1
- Press release
- Makes a Regulation FD disclosure (7.01)
- Discloses other events (8.01)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Phio Pharmaceuticals PHIO public float $11M, Jun 30, 2025
- Palisade Bio PALI public float $11M, Jun 30, 2025
- Citius Pharmaceuticals CTXR public float $11M, Mar 31, 2025, over 18 months old
- Brainstorm Cell Therapeutics BCLI public float $10M, Jun 30, 2025
- Cocrystal Pharma COCP public float $12M, Jun 30, 2025